Cell Culture: The World Market for Media, Sera, and Reagents

Kalorama Information
January 1, 2007
162 Pages - SKU: KLI1354382
Attention: There is an updated edition available for this report.
Countries covered: Global

As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals.

This report is focused on cell culture used in the research and production of biopharmaceuticals, analyzing the world cell culture market and the major trends driving this market in three specific segments:

  • Media,
  • Sera, and
  • Reagents

In addition to a thorough discussion of the technologies and techniques currently employed and emerging in the cell culture area, the Kalorama's exhaustive report provides specific information on:

  • Market Size, growth, and forecasts of the segments through 2011
  • Competitive Market Share by leading supplier as of 2005.
  • Estimated Market Share by Media Type (this is not available in other reports)
  • Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, seasonal vaccine production, biomedical R&D directions, and the future of transgenic plant and animal production.
  • Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems
  • Discussion of the trends and preferences in media types vying for dominance in the market, including the following:
    • ADCF - animal derived component free media
    • CD - chemically defined media
    • CSFM - complete serum free medium
    • PF - protein free media
    • SF - serum free media
    • SFM - serum free medium
  • Profiles of 28 leading suppliers and information about M&A activities since 2003.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.




More Biopharmaceuticals reports by Kalorama Information

Biopharmaceutical and Vaccine Production Markets by Kalorama Information
Biopharmaceutical and Vaccine Production Markets Though biotechnology has created many new therapies and vaccines – including products to treat cancer, diabetes, HIV/AIDS and autoimmune disorders ...
The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition by Kalorama Information
The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, ...
Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition by Kalorama Information
Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent ...
Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccines and Biologics by Kalorama Information
As researchers work to improve drug properties through drug design and molecular modeling, the line between drug delivery and drug substance will become more and ...
See all reports like this >>

More Global Biopharmaceuticals reports

Biopharmaceutical Companies (Global) - Industry Report by Plimsoll Publishing Ltd.
Plimsoll’s Biopharmaceutical Companies (Global) analysis is the most definitive and accurate study of the Biopharmaceutical Companies (Global) sector in 2014.The report is split into two ...
Biopharmaceutical Companies, Global by Plimsoll Publishing Ltd.
Biopharmaceutical Companies Global Analysis displays a summary of the Biopharmaceutical Companies Global market and presents a comprehensive individual analysis on the top 180 companies, ...
PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market by GlobalData
PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars MarketSummaryGlobalData’s report, PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market, provides strategic ...
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets by BCC Research
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets The global market for Multiple Sclerosis (MS) disease-modifying products reached $10.1 billion in 2012 and ...
See all reports like this >>

 

SELECT A LICENSE

    Hard Copy Mail Delivery  USD 4,300  
    Global Site License  USD 7,800  
    Online Download plus 1 Hard Copy  USD 4,700  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!